COO
HoldUnloved QualityThe Cooper Companies, Inc. · Healthcare · United States · $13.9B · Avg Vol: $188M/d
Unloved Quality: Strong and cheap, but the market has not turned yet. Patience required.
ABOUT THE COOPER COMPANIES, INC.
Read
The Cooper Companies, Inc. is a global medical device company operating through two distinct segments: CooperVision, a leading manufacturer of contact lenses, and CooperSurgical, a provider of women's healthcare solutions. CooperVision holds a dominant position in specialty contact lenses, while CooperSurgical offers innovative products supporting fertility, diagnostics, and surgical procedures. The company's focus on high-growth, niche medical device markets, backed by strong R&D, provides a resilient business model in the healthcare sector.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.3B | 3.6B | 3.9B | 4.1B | 7.3% | 4.2B | 4.2B | 4.4B | 3.8% |
| EPS | 1.96 | 1.49 | 1.97 | 1.91 | -0.7% | 2.91 | 2.10 | 2.18 | 6.7% |
| Shares | 197.2M | 198.1M | 199.6M | 195.9M | -0.7% | 190.2M | — | — | — |
| Debt | 2.8B | 2.6B | 2.6B | 2.5B | -3.2% | 2.8B | — | — | — |
| Equity | 7.2B | 7.6B | 8.1B | 8.2B | 4.7% | — | — | — | — |
| Op CF | 692.4M | 607.5M | 709.3M | 796.1M | 4.8% | 1.0B | — | — | — |
| Inv CF | -1.8B | -449.0M | -764.6M | -372.9M | — | — | — | — | — |
| Fin CF | 1.2B | -173.9M | 39.2M | -425.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of COO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| COO | The Cooper Companies, Inc.(you) | $13.9B | 64 | Hold |
| BAX | Baxter International Inc. | $13.5B | 73 | Buy |
| AVTR | Avantor, Inc. | $9.9B | 70 | Buy |
| TFX | Teleflex Incorporated | $5.9B | 66 | Buy |
| RGEN | Repligen Corporation | $9.9B | 50 | Hold |
| ATR | AptarGroup, Inc. | $8.5B | 74 | Buy |
| WST | West Pharmaceutical Services, Inc. | $23.7B | 74 | Buy |
| SOLV | Solventum Corporation | $15.5B | 83 | Strong Buy |
| ICUI | ICU Medical, Inc. | $4.4B | 63 | Hold |
| ALGN | Align Technology, Inc. | $11.2B | 85 | Strong Buy |
Peer medians: ROE -31.0% · P/E 25.2x · Gross margin 58.3%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.